HSA — authorised 13 August 1962
- Marketing authorisation holder: KING PHARMS
- Status: likely_approved
🇸🇬 Skelaxin in Singapore
HSA authorised Skelaxin on 13 August 1962
Marketing authorisation
Skelaxin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in Singapore
Frequently asked questions
Is Skelaxin approved in Singapore?
Yes. HSA authorised it on 13 August 1962.
Who is the marketing authorisation holder for Skelaxin in Singapore?
KING PHARMS holds the Singaporean marketing authorisation.